Fate Therapeutics has announced encouraging initial data from the FT819 phase 1 autoimmunity study for people with ...

Its immuno-oncology pipeline includes iPSC-derived natural killer (NK) cells and T-cell product candidates. A phase I study of FT819, a T-cell product candidate for patients with systemic lupus ...

Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Hold rating on Fate Therapeutics (FATE – Research Report). The ...

Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm Adding FT819 to Maintenance Therapy without ...

Satellite images reveal Russian military equipment being prepared for loading, a possible prelude to its withdrawal from Syria. Travis Timmerman, an American who was found earlier this week, was ...

Months Before C.E.O.’s Killing, the Suspect Went Silent. Where Was He? New details are emerging about Luigi Mangione’s growing impatience with “a capitalist society” and his search for ...

Dec. 11, 2024 — Many vitamins are produced in chemical factories, often synthetically, but researchers have succeeded in developing a natural and simple method for producing vitamin B2: by ...

South Africa sweep Sri Lanka 2-0 to lead World Test Championship table Maharaj’s five-for helps South Africa beat Sri Lanka by 109 runs and leap ahead of Australia and India on the WTC table ...

Dec. 13, 2024 — Researchers have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses. A better understanding of its structure may help optimize ...

Social media posts from Luigi Mangione show the man suspected of killing UnitedHealthcare CEO Brian Thompson underwent successful back surgery last year that alleviated debilitating chronic pain ...